Table 6.
Synergistic effect of Xa-AgNPs and Ff-AgNPs and antibiotics against bacteria strains.
| Diameter of the zone of inhibition of Xa-AgNPs and Ff-AgNPs (5 mg/mL) with antibiotics (mm) | |||
|---|---|---|---|
| Bacteria strains | Xa-AgNPsa + Antibiotic | Ff-AgNPsa + Antibiotic | (+) Control ‘Antibiotics’ |
| MRSA | 22 ± 0 | 24 ± 0 | TE 30: 18 ± 0 |
| S. aureus ATCC | 21.5 ± 0.5 | 22 ± 0 | TE30: 21 ± 0 |
| VRE | 26 ± 0 | 26 ± 0 | LZD30: 21 ± 0 |
| E. faecium ATCC | 25.1 ± 0.2 | 27 ± 0 | LZD30: 22 ± 0 |
| P. aeruginosa MDR | 13 ± 0 | 13.5 ± 0 | CN10: 11 ± 0 |
| P. aeruginosa ATCC | 20 ± 0 | 20 ± 0 | CN10:18 ± 0 |
| E. coli MDR | 11 ± 0 | 11 ± 0 | Amp10: 10 ± 0 |
| E. coli ATCC | 21 ± 0 | 20.6 ± 0.5 | Amp10: 20 ± 0 |
aXa-AgNPs are the AgNPs prepared using Xanthoria parietina and Ff-AgNPs are the AgNPs prepared using Flavopunctelia flaventior.